[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5794 Introduced in House (IH)]

<DOC>






116th CONGRESS
  2d Session
                                H. R. 5794

To amend the Public Health Service Act to expand research and education 
      with respect to endometrial cancer, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            February 6, 2020

 Mr. David Scott of Georgia (for himself, Ms. Norton, Mr. Cohen, Mrs. 
Beatty, Ms. Kelly of Illinois, Mr. Bishop of Georgia, Mr. Butterfield, 
    Mr. Carson of Indiana, Ms. Clarke of New York, Mr. Thompson of 
  Mississippi, Ms. Pressley, Mr. Lawson of Florida, Mr. Hastings, Ms. 
 Blunt Rochester, Ms. Johnson of Texas, Mr. Green of Texas, Ms. Fudge, 
  Mr. Payne, Ms. Bass, Ms. Lee of California, Mr. Rush, Mr. Brown of 
 Maryland, Mr. Danny K. Davis of Illinois, Mr. Richmond, Mr. Jeffries, 
    Mr. Meeks, Ms. Jackson Lee, Mr. Johnson of Georgia, Mrs. Watson 
Coleman, Ms. Plaskett, and Mr. Clyburn) introduced the following bill; 
       which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To amend the Public Health Service Act to expand research and education 
      with respect to endometrial cancer, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Endometrial Cancer Research and 
Education Act of 2020''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) Endometrial cancer is cancer of the lining of the 
        uterus (or endometrium) and is the most common form of uterine 
        cancer.
            (2) Endometrial cancer is the fourth most common cancer 
        diagnosed in women, after breast, lung, and colon cancer.
            (3) Endometrial cancer mainly affects postmenopausal women, 
        with most women diagnosed between age 55 and 64.
            (4) Women with polycystic ovary syndrome (PCOS) and uterine 
        leiomyoma have an increased risk of developing endometrial 
        cancer.
            (5) Unlike most other types of cancer, the incidence of 
        endometrial cancer, particularly aggressive subtypes of such 
        cancer, has been increasing in the United States among all 
        women, particularly among African-American and Asian women, 
        with a 2.5 annual percent change for both groups.
            (6) In comparison to non-Hispanic White women, African-
        American women have significantly higher incidence rates of 
        aggressive endometrial cancers.
            (7) Such incidence rates for Hispanic and Asian women are 
        equal to or lower than such incidence rates for non-Hispanic 
        White women.
            (8) Although non-Hispanic White women are more likely to be 
        diagnosed with endometrial cancer in comparison to African-
        American women, the rate of mortality is higher for African-
        American women.
            (9) Currently, the cause of such disparity is unknown. 
        Researchers have studied the disparity in relation to the time 
        between diagnosis and treatment of endometrial cancer, 
        including socioeconomic factors.

SEC. 3. EXPANDING RESEARCH AND EDUCATION WITH RESPECT TO ENDOMETRIAL 
              CANCER.

    (a) National Institutes of Health.--Part B of title IV of the 
Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding 
at the end the following new section:

``SEC. 409K. ENDOMETRIAL CANCER.

    ``(a) In General.--The Director of NIH shall--
            ``(1) expand, intensify, and coordinate programs to conduct 
        and support research with respect to endometrial cancer; and
            ``(2) communicate to medical professionals and researchers, 
        including through the endometrial cancer public education 
        program established under section 399V-7, the disparity in the 
        diagnosis of endometrial cancer between African-American women 
        and non-Hispanic White women and any new research relating to 
        endometrial cancer.
    ``(b) Coordination With Other Institutes.--The Director of NIH 
shall coordinate activities carried out by the Director pursuant to 
subsection (a) with similar activities carried out by--
            ``(1) the Director of the Eunice Kennedy Shriver National 
        Institute of Child Health and Human Development;
            ``(2) the Director of the National Institute on Minority 
        Health and Health Disparities; and
            ``(3) the Director of the Office of Research on Women's 
        Health.
    ``(c) Authorization of Appropriations.--For purposes of carrying 
out this section, there is authorized to be appropriated $500,000 for 
each of fiscal years 2021 through 2023.''.
    (b) Centers for Disease Control and Prevention.--Part P of title 
III of the Public Health Service Act (42 U.S.C. 280g et seq.) is 
amended by adding at the end the following new section:

``SEC. 399V-7. ENDOMETRIAL CANCER PUBLIC EDUCATION PROGRAM.

    ``(a) In General.--The Secretary, acting through the Director of 
the Centers for Disease Control and Prevention, shall develop and 
disseminate to the public informational materials on endometrial 
cancer, including the incidence rate of such cancer, the risk factors 
for developing such cancer, the increased risk for ethnic minority 
women to develop such cancer, and the range of available treatments for 
such cancer. Any informational material developed pursuant to the 
previous sentence may be transmitted to a nonprofit organization; 
institution of higher education; Federal, State, or local agency; or 
media entity for purposes of disseminating such material to the public.
    ``(b) Consultation.--In developing and disseminating informational 
materials under subsection (a), the Director of the Centers for Disease 
Control and Prevention shall consult with the Administrator of the 
Health Resources and Services Administration.
    ``(c) Authorization of Appropriations.--For purposes of carrying 
out this section, there is authorized to be appropriated such sums as 
may be necessary for each of fiscal years 2021 through 2023.''.
                                 <all>